Literature DB >> 27276562

Exome Sequencing and the Management of Neurometabolic Disorders.

Maja Tarailo-Graovac1, Casper Shyr1, Colin J Ross1, Gabriella A Horvath1, Ramona Salvarinova1, Xin C Ye1, Lin-Hua Zhang1, Amit P Bhavsar1, Jessica J Y Lee1, Britt I Drögemöller1, Mena Abdelsayed1, Majid Alfadhel1, Linlea Armstrong1, Matthias R Baumgartner1, Patricie Burda1, Mary B Connolly1, Jessie Cameron1, Michelle Demos1, Tammie Dewan1, Janis Dionne1, A Mark Evans1, Jan M Friedman1, Ian Garber1, Suzanne Lewis1, Jiqiang Ling1, Rupasri Mandal1, Andre Mattman1, Margaret McKinnon1, Aspasia Michoulas1, Daniel Metzger1, Oluseye A Ogunbayo1, Bojana Rakic1, Jacob Rozmus1, Peter Ruben1, Bryan Sayson1, Saikat Santra1, Kirk R Schultz1, Kathryn Selby1, Paul Shekel1, Sandra Sirrs1, Cristina Skrypnyk1, Andrea Superti-Furga1, Stuart E Turvey1, Margot I Van Allen1, David Wishart1, Jiang Wu1, John Wu1, Dimitrios Zafeiriou1, Leo Kluijtmans1, Ron A Wevers1, Patrice Eydoux1, Anna M Lehman1, Hilary Vallance1, Sylvia Stockler-Ipsiroglu1, Graham Sinclair1, Wyeth W Wasserman1, Clara D van Karnebeek1.   

Abstract

BACKGROUND: Whole-exome sequencing has transformed gene discovery and diagnosis in rare diseases. Translation into disease-modifying treatments is challenging, particularly for intellectual developmental disorder. However, the exception is inborn errors of metabolism, since many of these disorders are responsive to therapy that targets pathophysiological features at the molecular or cellular level.
METHODS: To uncover the genetic basis of potentially treatable inborn errors of metabolism, we combined deep clinical phenotyping (the comprehensive characterization of the discrete components of a patient's clinical and biochemical phenotype) with whole-exome sequencing analysis through a semiautomated bioinformatics pipeline in consecutively enrolled patients with intellectual developmental disorder and unexplained metabolic phenotypes.
RESULTS: We performed whole-exome sequencing on samples obtained from 47 probands. Of these patients, 6 were excluded, including 1 who withdrew from the study. The remaining 41 probands had been born to predominantly nonconsanguineous parents of European descent. In 37 probands, we identified variants in 2 genes newly implicated in disease, 9 candidate genes, 22 known genes with newly identified phenotypes, and 9 genes with expected phenotypes; in most of the genes, the variants were classified as either pathogenic or probably pathogenic. Complex phenotypes of patients in five families were explained by coexisting monogenic conditions. We obtained a diagnosis in 28 of 41 probands (68%) who were evaluated. A test of a targeted intervention was performed in 18 patients (44%).
CONCLUSIONS: Deep phenotyping and whole-exome sequencing in 41 probands with intellectual developmental disorder and unexplained metabolic abnormalities led to a diagnosis in 68%, the identification of 11 candidate genes newly implicated in neurometabolic disease, and a change in treatment beyond genetic counseling in 44%. (Funded by BC Children's Hospital Foundation and others.).

Entities:  

Mesh:

Year:  2016        PMID: 27276562      PMCID: PMC4983272          DOI: 10.1056/NEJMoa1515792

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  34 in total

1.  Model network: Canadian program aims to generate models for rare disease.

Authors:  Katherine Ellen Foley
Journal:  Nat Med       Date:  2015-11       Impact factor: 53.440

2.  Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study.

Authors:  Anita Rauch; Dagmar Wieczorek; Elisabeth Graf; Thomas Wieland; Sabine Endele; Thomas Schwarzmayr; Beate Albrecht; Deborah Bartholdi; Jasmin Beygo; Nataliya Di Donato; Andreas Dufke; Kirsten Cremer; Maja Hempel; Denise Horn; Juliane Hoyer; Pascal Joset; Albrecht Röpke; Ute Moog; Angelika Riess; Christian T Thiel; Andreas Tzschach; Antje Wiesener; Eva Wohlleber; Christiane Zweier; Arif B Ekici; Alexander M Zink; Andreas Rump; Christa Meisinger; Harald Grallert; Heinrich Sticht; Annette Schenck; Hartmut Engels; Gudrun Rappold; Evelin Schröck; Peter Wieacker; Olaf Riess; Thomas Meitinger; André Reis; Tim M Strom
Journal:  Lancet       Date:  2012-09-27       Impact factor: 79.321

3.  FORGE Canada Consortium: outcomes of a 2-year national rare-disease gene-discovery project.

Authors:  Chandree L Beaulieu; Jacek Majewski; Jeremy Schwartzentruber; Mark E Samuels; Bridget A Fernandez; Francois P Bernier; Michael Brudno; Bartha Knoppers; Janet Marcadier; David Dyment; Shelin Adam; Dennis E Bulman; Steve J M Jones; Denise Avard; Minh Thu Nguyen; Francois Rousseau; Christian Marshall; Richard F Wintle; Yaoqing Shen; Stephen W Scherer; Jan M Friedman; Jacques L Michaud; Kym M Boycott
Journal:  Am J Hum Genet       Date:  2014-06-05       Impact factor: 11.025

4.  RMND1 deficiency associated with neonatal lactic acidosis, infantile onset renal failure, deafness, and multiorgan involvement.

Authors:  Alexandre Janer; Clara Dm van Karnebeek; Florin Sasarman; Hana Antonicka; Malak Al Ghamdi; Casper Shyr; Mary Dunbar; Sylvia Stockler-Ispiroglu; Colin J Ross; Hilary Vallance; Janis Dionne; Wyeth W Wasserman; Eric A Shoubridge
Journal:  Eur J Hum Genet       Date:  2015-01-21       Impact factor: 4.246

5.  Griscelli syndrome type 2: long-term follow-up after unrelated donor bone marrow transplantation.

Authors:  Alfredo Rossi; Riccardo G Borroni; Anna Maria Carrozzo; Catia de Felice; Adriana Menichelli; Marta Carlesimo; Stefano Calvieri
Journal:  Dermatology       Date:  2009-03-06       Impact factor: 5.366

6.  Demographic and epidemiological determinants of healthcare costs in Netherlands: cost of illness study.

Authors:  W J Meerding; L Bonneux; J J Polder; M A Koopmanschap; P J van der Maas
Journal:  BMJ       Date:  1998-07-11

7.  Brain dopamine-serotonin vesicular transport disease and its treatment.

Authors:  Jennifer J Rilstone; Reem A Alkhater; Berge A Minassian
Journal:  N Engl J Med       Date:  2013-01-30       Impact factor: 91.245

8.  An update on serine deficiency disorders.

Authors:  S N van der Crabben; N M Verhoeven-Duif; E H Brilstra; L Van Maldergem; T Coskun; E Rubio-Gozalbo; R Berger; T J de Koning
Journal:  J Inherit Metab Dis       Date:  2013-03-06       Impact factor: 4.982

9.  Whole-exome sequencing in undiagnosed genetic diseases: interpreting 119 trios.

Authors:  Xiaolin Zhu; Slavé Petrovski; Pingxing Xie; Elizabeth K Ruzzo; Yi-Fan Lu; K Melodi McSweeney; Bruria Ben-Zeev; Andreea Nissenkorn; Yair Anikster; Danit Oz-Levi; Ryan S Dhindsa; Yuki Hitomi; Kelly Schoch; Rebecca C Spillmann; Gali Heimer; Dina Marek-Yagel; Michal Tzadok; Yujun Han; Gordon Worley; Jennifer Goldstein; Yong-Hui Jiang; Doron Lancet; Elon Pras; Vandana Shashi; Duncan McHale; Anna C Need; David B Goldstein
Journal:  Genet Med       Date:  2015-01-15       Impact factor: 8.822

10.  X-exome sequencing of 405 unresolved families identifies seven novel intellectual disability genes.

Authors:  H Hu; S A Haas; J Chelly; H Van Esch; M Raynaud; A P M de Brouwer; S Weinert; G Froyen; S G M Frints; F Laumonnier; T Zemojtel; M I Love; H Richard; A-K Emde; M Bienek; C Jensen; M Hambrock; U Fischer; C Langnick; M Feldkamp; W Wissink-Lindhout; N Lebrun; L Castelnau; J Rucci; R Montjean; O Dorseuil; P Billuart; T Stuhlmann; M Shaw; M A Corbett; A Gardner; S Willis-Owen; C Tan; K L Friend; S Belet; K E P van Roozendaal; M Jimenez-Pocquet; M-P Moizard; N Ronce; R Sun; S O'Keeffe; R Chenna; A van Bömmel; J Göke; A Hackett; M Field; L Christie; J Boyle; E Haan; J Nelson; G Turner; G Baynam; G Gillessen-Kaesbach; U Müller; D Steinberger; B Budny; M Badura-Stronka; A Latos-Bieleńska; L B Ousager; P Wieacker; G Rodríguez Criado; M-L Bondeson; G Annerén; A Dufke; M Cohen; L Van Maldergem; C Vincent-Delorme; B Echenne; B Simon-Bouy; T Kleefstra; M Willemsen; J-P Fryns; K Devriendt; R Ullmann; M Vingron; K Wrogemann; T F Wienker; A Tzschach; H van Bokhoven; J Gecz; T J Jentsch; W Chen; H-H Ropers; V M Kalscheuer
Journal:  Mol Psychiatry       Date:  2015-02-03       Impact factor: 15.992

View more
  108 in total

1.  The Genomics of Arthrogryposis, a Complex Trait: Candidate Genes and Further Evidence for Oligogenic Inheritance.

Authors:  Davut Pehlivan; Yavuz Bayram; Nilay Gunes; Zeynep Coban Akdemir; Anju Shukla; Tatjana Bierhals; Burcu Tabakci; Yavuz Sahin; Alper Gezdirici; Jawid M Fatih; Elif Yilmaz Gulec; Gozde Yesil; Jaya Punetha; Zeynep Ocak; Christopher M Grochowski; Ender Karaca; Hatice Mutlu Albayrak; Periyasamy Radhakrishnan; Haktan Bagis Erdem; Ibrahim Sahin; Timur Yildirim; Ilhan A Bayhan; Aysegul Bursali; Muhsin Elmas; Zafer Yuksel; Ozturk Ozdemir; Fatma Silan; Onur Yildiz; Osman Yesilbas; Sedat Isikay; Burhan Balta; Shen Gu; Shalini N Jhangiani; Harsha Doddapaneni; Jianhong Hu; Donna M Muzny; Eric Boerwinkle; Richard A Gibbs; Konstantinos Tsiakas; Maja Hempel; Katta Mohan Girisha; Davut Gul; Jennifer E Posey; Nursel H Elcioglu; Beyhan Tuysuz; James R Lupski
Journal:  Am J Hum Genet       Date:  2019-06-20       Impact factor: 11.025

Review 2.  Exome Sequencing in Clinical Hepatology.

Authors:  Sílvia Vilarinho; Pramod K Mistry
Journal:  Hepatology       Date:  2019-12       Impact factor: 17.425

3.  Bi-allelic GOT2 Mutations Cause a Treatable Malate-Aspartate Shuttle-Related Encephalopathy.

Authors:  Clara D M van Karnebeek; Rúben J Ramos; Xiao-Yan Wen; Maja Tarailo-Graovac; Joseph G Gleeson; Cristina Skrypnyk; Koroboshka Brand-Arzamendi; Farhad Karbassi; Mahmoud Y Issa; Robin van der Lee; Britt I Drögemöller; Janet Koster; Justine Rousseau; Philippe M Campeau; Youdong Wang; Feng Cao; Meng Li; Jos Ruiter; Jolita Ciapaite; Leo A J Kluijtmans; Michel A A P Willemsen; Judith J Jans; Colin J Ross; Liesbeth T Wintjes; Richard J Rodenburg; Marleen C D G Huigen; Zhengping Jia; Hans R Waterham; Wyeth W Wasserman; Ronald J A Wanders; Nanda M Verhoeven-Duif; Maha S Zaki; Ron A Wevers
Journal:  Am J Hum Genet       Date:  2019-08-15       Impact factor: 11.025

4.  Sialic acid catabolism by N-acetylneuraminate pyruvate lyase is essential for muscle function.

Authors:  Xiao-Yan Wen; Maja Tarailo-Graovac; Koroboshka Brand-Arzamendi; Anke Willems; Bojana Rakic; Karin Huijben; Afitz Da Silva; Xuefang Pan; Suzan El-Rass; Robin Ng; Katheryn Selby; Anju Mary Philip; Junghwa Yun; X Cynthia Ye; Colin J Ross; Anna M Lehman; Fokje Zijlstra; N Abu Bakar; Britt Drögemöller; Jacqueline Moreland; Wyeth W Wasserman; Hilary Vallance; Monique van Scherpenzeel; Farhad Karbassi; Martin Hoskings; Udo Engelke; Arjan de Brouwer; Ron A Wevers; Alexey V Pshezhetsky; Clara Dm van Karnebeek; Dirk J Lefeber
Journal:  JCI Insight       Date:  2018-12-20

5.  Will New Genetic Techniques Like Exome Sequencing and Others Obviate the Need for Clinical Expertise? Yes.

Authors:  Vincenzo Bonifati
Journal:  Mov Disord Clin Pract       Date:  2016-10-17

6.  Monogenic immune disorders and severe atopic disease.

Authors:  Catherine M Biggs; Henry Y Lu; Stuart E Turvey
Journal:  Nat Genet       Date:  2017-07-27       Impact factor: 38.330

Review 7.  DNA sequencing technologies: 2006-2016.

Authors:  Elaine R Mardis
Journal:  Nat Protoc       Date:  2017-01-05       Impact factor: 13.491

8.  Biallelic variants in the ciliary gene TMEM67 cause RHYNS syndrome.

Authors:  Francesco Brancati; Letizia Camerota; Emma Colao; Virginia Vega-Warner; Xiangzhong Zhao; Ruixiao Zhang; Irene Bottillo; Marco Castori; Alfredo Caglioti; Federica Sangiuolo; Giuseppe Novelli; Nicola Perrotti; Edgar A Otto
Journal:  Eur J Hum Genet       Date:  2018-06-11       Impact factor: 4.246

9.  Evolutionary conservation of human ketodeoxynonulosonic acid production is independent of sialoglycan biosynthesis.

Authors:  Kunio Kawanishi; Sudeshna Saha; Sandra Diaz; Michael Vaill; Aniruddha Sasmal; Shoib S Siddiqui; Biswa Choudhury; Kumar Sharma; Xi Chen; Ian C Schoenhofen; Chihiro Sato; Ken Kitajima; Hudson H Freeze; Anja Münster-Kühnel; Ajit Varki
Journal:  J Clin Invest       Date:  2021-03-01       Impact factor: 14.808

10.  Exome Sequencing in Children.

Authors:  Elisa A Mahler; Jessika Johannsen; Konstantinos Tsiakas; Katja Kloth; Sabine Lüttgen; Chris Mühlhausen; Bader Alhaddad; Tobias B Haack; Tim M Strom; Fanny Kortüm; Thomas Meitinger; Ania C Muntau; René Santer; Christian Kubisch; Davor Lessel; Jonas Denecke; Maja Hempel
Journal:  Dtsch Arztebl Int       Date:  2019-03-22       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.